Bhaskar Anand - Jan 3, 2023 Form 4 Insider Report for REATA PHARMACEUTICALS INC (RETA)

Role: VP, Chief Accounting Officer
Signature: /s/ Tracy Herson, attorney-in-fact
Stock symbol: RETA
Transactions as of: Jan 3, 2023
Transactions value $: $0
Form type: 4
Date filed: 1/4/2023, 03:07 PM
Previous filing: Jan 5, 2022
Next filing: Mar 2, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RETA	Class A common stock	Award	$0	+8.25K	+50%	$0.00	24.8K	Jan 3, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RETA	Employee Stock Option (right-to-buy)	Award	$0	+33.5K		$0.00	33.5K	Jan 3, 2023	Class A common stock	33.5K	$36.71	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares represent Restricted Stock Units, which vest 1/16th of each grant on March 6, May 15, August 15, and November 15 of each year, subject to continued service through each vesting date.
F2	The options vest 1/16th of each grant on March 6, May 15, August 15, and November 15 of each year, subject to continued service through each vesting date.